Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0G5DU
|
||||
Former ID |
DNC009607
|
||||
Drug Name |
4-Propyl-1-[3-(phenylpropoxy)propyl]piperidine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
Download2D MOL |
||||
Formula |
C20H33NO
|
||||
Canonical SMILES |
CCCC1CCN(CC1)CCCOCCCC2=CC=CC=C2
|
||||
InChI |
1S/C20H33NO/c1-2-8-19-12-15-21(16-13-19)14-7-18-22-17-6-11-20-9-4-3-5-10-20/h3-5,9-10,19H,2,6-8,11-18H2,1H3
|
||||
InChIKey |
STTDWMNBHHXZBO-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Histamine H3 receptor | Target Info | Inhibitor | [1] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
Reactome | Histamine receptors | ||||
G alpha (i) signalling events | |||||
WikiPathways | Monoamine Transport | ||||
GPCRs, Class A Rhodopsin-like | |||||
GPCR ligand binding | |||||
GPCR downstream signaling | |||||
References | |||||
REF 1 | Bioorg Med Chem. 2008 Sep 15;16(18):8729-36. Epub 2008 Jul 29.Piperidine variations in search for non-imidazole histamine H(3) receptor ligands. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.